Chardan Affirms ARIAD (ARIA) at 'Buy'; Narrower Label Impacts Iclusig Usage
Go back to Chardan Affirms ARIAD (ARIA) at 'Buy'; Narrower Label Impacts Iclusig Usage| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 26.31 -0.17 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.48 | 52 Week High | $14.34 | |||
| Open | $26.31 | 52 Week Low | $4.37 | |||
| Day High | $26.31 | P/E | N/A | |||
| Day Low | $26.31 | EPS | $-1.45 | |||
| Volume | 134 | |||||

